Allergies and asthma are a continuing health problem in most developed countries, but just how do these ailments develop over the course of a childhood? In a population-based study designed to help answer this question, researchers in Norway found that 40 per cent — or two of five — of nearly 5,000 two-year-olds had at least one reported allergy-related disorder.

AccuDial® Pharmaceutical, Inc. delivered a power-packed launch with their new family of eight over-the-counter (OTC) medications in Canada. Colorful floor displays enjoyed prominent placement in every Quebec Walmart pharmacy, and were filled with AccuDial’s pain and fever, allergy, and cough and cold pediatric medications. By the end of March, Children’s AccuDial should be available in over 50% of Canadian pharmacies including other major grocery and drugstore outlets…

Too many people are self-diagnosing food allergies and could be restricting their diet unnecessarily, according to a new report by the University of Portsmouth and commissioned by the Flour Advisory Bureau. Research shows that up to 20 per cent of adults think they suffer from a food allergy or food intolerance.

Exposing patients with chronic sinus disease to allergens and then obtaining repeated images by X-ray or ultrasound reveals that nasal allergies may be involved in some cases of chronic sinus disease, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. Chronic disease of the maxillary sinus (the sinus cavity located in the mid-face beneath the cheeks, on either side of the nose) is common and affects a wide population of adults and children, according to background information in the article…

Exposing patients with chronic sinus disease to allergens and then obtaining repeated images by X-ray or ultrasound reveals that nasal allergies may be involved in some cases of chronic sinus disease, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery, one of the JAMA/Archives journals. Chronic disease of the maxillary sinus (the sinus cavity located in the mid-face beneath the cheeks, on either side of the nose) is common and affects a wide population of adults and children, according to background information in the article…

Researchers from the La Jolla Institute for Allergy & Immunology will take aim at several of the world’s most dangerous infectious diseases - tuberculosis, malaria and dengue virus — in a five-year, $18.8 million federally-funded set of projects seeking to make new inroads toward vaccines against the disorders. The Institute received four project awards totaling $18.8 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to fund the study…

Researchers from the University of Pennsylvania and the University of Georgia have been awarded a five-year, $14.6 million contract from the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health, to expand and extend work on the Eukaryotic Pathogen Genome Database Resource, http://EuPathDB.org. This revolutionary open database enables scientists to examine genes, genomes, isolates, and other attributes related to a variety of important human pathogens…

Late introduction of solid foods may increase the risk of allergic sensitization to food and inhalant allergens. In the study, “Age at the Introduction of Solid Foods During the First Year and Allergic Sensitization at Age 5 Years,” published in the January issue of Pediatrics, researchers examined the diets and allergic sensitivities of 994 children with susceptibility to type 1 diabetes. Results indicate that late introduction of solid foods was associated with increased allergic sensitization to food and inhalant allergens…

Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have announced their support of The European Federation of Allergy and Airways Diseases Patients` Associations` (EFA) call for urgent improvement in the care of people with COPD.

Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development.